High-affinity PAC1/VIP receptors are present on patient-derived GBM cultures; PACAP/VIP exposure modulates cAMP-EPAC-Rap1 and MAPK cascades, finely balancing proliferation and motility in a context-dependent manner. This evidence concerns the gene ADCYAP1 and glioblastoma.